NCT00454363 2020-04-03
Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer
National Cancer Institute (NCI)
Phase 2 Completed
National Cancer Institute (NCI)
AstraZeneca
Columbia University
University of Alabama at Birmingham
Takeda